DRKS00019006已完成未知
Clinical trial Retterspitz cream in patients with various manifestations of injuries of the muscular, tendon and joint system
Retterspitz GmbH0 个研究点目标入组 130 人开始时间: 2019年10月24日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized controlled study
- 盲法
- Blinded (masking used)
入排标准
- 年龄范围
- 18 Years 至 85 Years（—）
- 性别
- All
入选标准
- •Included are patients with acute blunt injuries of the muscular, tendon and joint system, which are not permanently subject to therapy. The trauma must not be older than 48 hours. The presence of at least one of the following types of injury must be ensured:
- •- swelling
- •- hematoma
- •Before being included in the study, the investigator will ensure that there is no serious traumatic or chronic finding and that long-term treatment is not required
排除标准
- •- Patients with an open wound on the affected part of the body
- •- Patients with fractures, torn ligaments, surgical procedures, with recurrent chronic complaints and local skin infections, which do not allow the study medication.
- •- Patients taking anticoagulation or anti-platelet drugs
- •- Age <18,> 85
- •- Allergy or intolerance to one or more of the ingredients used
- •- permanent use of painkillers
- •- Use of steroidal or non-steroidal anti-inflammatory drugs
- •within 48 hours of the onset of injury (topically, orally or intravenously)
- •- Pregnancy and breast feeding period
- •- Inability to adequately participate in the study
研究者
相似试验
已完成
不适用
Clinical trial Retterspitz lotion in patients with various manifestations of injuries of the muscular, tendon and joint systemvarious manifestations of muscle, tendon and joint injuriesDRKS00020252Retterspitz GmbH100
已完成
不适用
Clinical efficacy and safety of R0002 cream in the initial and maintenance therapies of lamellar ichthyosis (LI)amellar ichthyosis (LI)Skin and Connective Tissue DiseasesLamellar ichthyosis (LI)ISRCTN62315004Orfagen (France)80
尚未招募
3 期
Evaluation of the effectiveness of Raphanus sativus in melasmaIRCT20220223054106N1Tehran University of Medical Sciences25
已完成
3 期
The impact of Althaea officinalis formulation on controlling the symptoms of atopic dermatitisAtopic Eczema.Other atopic dermatitisIRCT2016102323235N5Vice chancellor for research, Mashhad University of Medical Sciences40
进行中（未招募）
1 期
Assessment of the activity of a new cream containing betamethasone dipropionate at 0.010%, 0.025% and 0.050% versus reference products using a vasoconstriction assay in healthy subjects.Topical treatment of inflammatory dermatosis linked to cutaneous drynessEUCTR2008-007173-20-FRPierre Fabre Dermatologie represented by Institut de Recherche Pierre Fabre40